drug

(budesonide + formoterol fumarate)

Marketedupdated 2mo ago

by AstraZeneca Pharmaceuticals LP

Approved

community read0 votes

indications

investigational

COPDAsthma

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Patent cliff

source: FDA Orange Book

first barrier falls

May 28, 2030

~3.9 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (2)

May 28, 2030formulationUS 107167533.9y
May 28, 2030method-of-use (U-3203)US 94150093.9y